Tandem Diabetes Care, Inc. recalls t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.
- Products
-
- t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology
- Company
- Tandem Diabetes Care, Inc.
- Where it was sold
-
US nationwide distribution including Puerto Rico.
Nationwide
- Barcodes
00850006613274- Units affected
- 85,863 applications
- About this recall
- t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology